慢性淋巴细胞白血病的免疫治疗。

IF 2.7 3区医学 Q2 HEMATOLOGY

Hematology-Oncology Clinics of North America Pub Date : 2025-07-08 DOI:10.1016/j.hoc.2025.05.010

Brian Sworder, Tanya Siddiqi

引用次数: 0

摘要

免疫疗法已经重新定义了许多淋巴瘤的治疗策略，包括慢性淋巴细胞白血病（CLL）和小淋巴细胞淋巴瘤（SLL）。本文综述了免疫治疗CLL/SLL的进展和疗效，特别是新型单克隆抗体、双特异性抗体和嵌合抗原受体t细胞治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Immunotherapy in Chronic Lymphocytic Leukemia.

Immune-based therapies have redefined treatment strategies for a number of lymphomas including chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). This review highlights the evolution and efficacy of immune-based therapies in CLL/SLL, especially the novel monoclonal antibodies, bispecific antibodies, and chimeric antigen receptor T-cell therapy.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Hematology-Oncology Clinics of North America 医学-血液学

CiteScore

4.10

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Hematology/Oncology Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Under the direction of an experienced guest editor, each issue focuses on a single topic in hematology and oncology, including hemostasis and thrombosis, molecular and cellular basis of hematology, coagulation disorders, and cancers—bone, gastrointestinal, head and neck, lymphomas, neuroendocrine, breast, renal cell, melanoma, and more.